Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-03-09 @ 4:09 AM
Study NCT ID:
NCT02049905
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2014-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Sponsor:
ImmunityBio, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALDOXORUBICIN-P3-STS-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None